...
首页> 外文期刊>APMIS: Acta Pathologica, Microbiologica et Immunologica Scandinavica >In vitro antimicrobial profile of Ureaplasma urealyticum from genital tract of childbearing-aged women in Northern and Southern Italy
【24h】

In vitro antimicrobial profile of Ureaplasma urealyticum from genital tract of childbearing-aged women in Northern and Southern Italy

机译:意大利北部和南部育龄妇女生殖道解脲脲原体的体外抗菌谱

获取原文
获取原文并翻译 | 示例

摘要

Ureaplasma urealyticum is an opportunistic pathogen during pregnancy and in newborns. Other clinical problems related to U. urealyticum infections are: no susceptibility to cell wall-active drugs, limits of antibiotic treatment in pregnancy, and spread of antimicrobial resistance. In addition, the results of antimicrobial susceptibility against U. urealyticum from various countries are few and controversial. The antimicrobial susceptibility of U. urealyticum, isolated from cervical swabs and collected from outpatient childbearing-aged women in Italy from 2009 to 2012, was performed against fluoroquinolones, macrolides, streptogramin and tetracyclines, using an available biochemical commercial kit and a specific solid culture medium, to improve the therapeutic management of these pathogenic agents. Ureaplasma urealyticum was detected in 49.4% of samples, but significant bacterial load was revealed in 29.8%. In vitro tetracyclines showed the best activity against U. urealyticum, followed by streptogramin, macrolides, and fluoroquinolones.
机译:解脲脲原体是妊娠和新生儿期间的机会病原体。与解脲支原体感染有关的其他临床问题是:对细胞壁活性药物不敏感,妊娠期抗生素治疗的局限性以及抗菌素耐药性的扩散。另外,来自各国的对解脲脲原体的抗菌药敏感性的结果很少且有争议。使用可用的生化商业试剂盒和特定的固体培养基,从2009年至2012年在意大利门诊育龄妇女中收集的宫颈拭子分离的解脲支原体对氟喹诺酮类,大环内酯类,链霉菌素和四环素类药物进行了药敏试验。 ,以改善这些病原体的治疗管理。在49.4%的样品中检出了解脲脲原体,但在29.8%的样品中发现了明显的细菌载量。体外四环素类药物对解脲脲原体表现出最好的活性,其次是链霉菌素,大环内酯类和氟喹诺酮类。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号